Hes1 Is Expressed in the Second Heart Field and Is Required for Outflow Tract Development by Rochais, Francesca et al.
Hes1 Is Expressed in the Second Heart Field and Is
Required for Outflow Tract Development
Francesca Rochais
1., Mathieu Dandonneau
1., Karim Mesbah
1, The ´re `se Jarry
1, Marie-Genevie `ve Mattei
2,
Robert G. Kelly
1*
1Developmental Biology Institute of Marseilles-Luminy, UMR 6216 CNRS-Universite ´ de la Me ´diterrane ´e, Campus de Luminy, Marseille, France, 2Inserm UMR 910, Faculte ´
de Me ´decine, Ho ˆpital d’Enfants de la Timone, Marseille, France
Abstract
Background: Rapid growth of the embryonic heart occurs by addition of progenitor cells of the second heart field to the
poles of the elongating heart tube. Failure or perturbation of this process leads to congenital heart defects. In order to
provide further insight into second heart field development we characterized the insertion site of a transgene expressed in
the second heart field and outflow tract as the result of an integration site position effect.
Results: Here we show that the integration site of the A17-Myf5-nlacZ-T55 transgene lies upstream of Hes1, encoding a basic
helix-loop-helix containing transcriptional repressor required for the maintenance of diverse progenitor cell populations
during embryonic development. Transgene expression in a subset of Hes1 expression sites, including the CNS, pharyngeal
epithelia, pericardium, limb bud and lung endoderm suggests that Hes1 is the endogenous target of regulatory elements
trapped by the transgene. Hes1 is expressed in pharyngeal endoderm and mesoderm including the second heart field.
Analysis of Hes1 mutant hearts at embryonic day 15.5 reveals outflow tract alignment defects including ventricular septal
defects and overriding aorta. At earlier developmental stages, Hes1 mutant embryos display defects in second heart field
proliferation, a reduction in cardiac neural crest cells and failure to completely extend the outflow tract.
Conclusions: Hes1 is expressed in cardiac progenitor cells in the early embryo and is required for development of the arterial
pole of the heart.
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Introduction
Cardiac progenitor cells of the second heart field (SHF)
contribute to the rapid growth of the embryonic heart by adding
cells to the poles of the heart tube [1]. At the arterial pole, SHF
cells give rise to right ventricular and outflow tract (OFT)
myocardium in addition to smooth muscle at the base of the
great arteries [2]. The SHF originates in splanchnic mesoderm
medial to the cardiac crescent from which the linear heart tube is
derived and is characterized by the expression of Fgf10, Isl1 and
Tbx1 [3–5]. The contribution of SHF derived cells to the heart is
coordinated with that of cardiac neural crest cells, which are
essential for dividing the embryonic OFT into the ascending aorta
and pulmonary trunk [6]. Interactions between these two cell types
in the pharyngeal region prior to their addition to the heart are
critical for normal OFT development; perturbations in SHF or
neural crest development results in failure to correctly elongate
and divide the OFT, resulting in congenital heart defects including
overriding aorta, double outlet right ventricle and common
arterial trunk [6–8]. Despite recent advances in our understanding
of OFT development, the molecular mechanisms maintaining
SHF cells in a progenitor state and regulating their contribution to
the elongating OFT remain poorly defined.
Notch intercellular signaling has been implicated in multiple
aspects of heart morphogenesis including cushion development,
trabecular growth, atrioventricular patterning, neural crest
differentiation and arterial pole development [9–12] (reviewed in
[13]). Mutations in the genes encoding the Notch ligand
JAGGED1 or the NOTCH2 receptor have been identified in
Alagille syndrome, associated with arterial pole defects including
tetralogy of Fallot, and mutations in Notch1 are associated with
aortic valve disease [14–16]. The Hey (Hairy and Enhancer of
Split related) family of basic-helix-loop-helix transcription factors
is thought to mediate Notch signaling in the developing
cardiovascular system [13]. Hey2 mutant mice display arterial
pole alignment and ventricular septal defects, associated with
activation of the atrial program in ventricular myocardium [17–
20]. Members of the related Hes (Hairy and Enhancer of Split)
family of transcription factors are also activated by Notch signaling
and play critical roles in development including maintaining
PLoS ONE | www.plosone.org 1 July 2009 | Volume 4 | Issue 7 | e6267progenitor cell populations, controlling binary cell fate decisions
and regulating boundary formation [21]. Hes1, encoding a
transcriptional repressor, plays central roles in cell proliferation
and differentiation processes in multiple cell types and is required
to maintain progenitor cells in an undifferentiated state [22–26].
Recently the A17-Myf5-nlacZ-T55 (T55) transgene has been
shown to be expressed in the SHF and OFT of the developing
mouse heart as a result of an integration site position effect [27].
We have localized the T55 transgene integration site upstream of
Hes1 and show that the transgene is expressed in a subset of Hes1
expression sites, including pharyngeal mesoderm of the SHF.
Although Hes1 has not been previously implicated in heart
development, mice lacking Hes1 display arterial pole alignment
anomalies, including overriding aorta and ventricular septal
defects, common components of congenital heart disease in
man. These defects are preceded by impaired deployment of cells
of the SHF and cardiac neural crest revealing a requirement for
Hes1 during OFT development.
Results
Characterization of the T55 transgene integration site
The Myf5 A17-nlacZ-T55 (T55) transgene is expressed in the
SHF and OFT as a result of an integration site position effect [27].
In order to identify new genes expressed in the SHF, we
characterized the transgene integration site. Using fluorescent in
situ hybridization (FISH) the insertion site was mapped to
chromosome 16 B2–B4 (Fig. 1A). An inverse PCR approach with
primers in the 59 region of the nlacZ reporter gene was used to
isolate a transgene-integration site junction fragment containing
256 bp of flanking sequence (Fig. 1B). Southern blot and PCR
analysis confirmed the presence of this junction specifically in
DNA from mice carrying the T55 transgene (Fig. 1C, data not
shown).
A nucleotide BLAST search using the 256 bp flanking sequence
revealed that this sequence mapped to chromosome 16 B2,
consistent with the FISH localization (Fig. 1D). The insertion site
junction lies between two genes, Optic Atrophy 1 (Opa1), encoding
a mitochondrial dynamin-related GTPase, and Hairy/Enhancer
of Split 1 (Hes1), encoding a basic-helix-loop-helix containing
transcriptional repressor, situated 258 kb and 224 kb from the
isolated sequence respectively. Opa1 and Hes1 are part of a 4 gene
synteny block centered on Hes1 that is conserved in zebrafish. The
expression profiles of Hes1 and Opa1, together with those of 4 EST
sequences and 2 predicted genes mapping between Hes1 and Opa1,
were evaluated by wholemount in situ hybridization at E9.5
(Fig. 2). Hes1 transcripts showed a regionalized expression profile
overlapping in distribution with the T55 transgene (Fig. 2A, Fig. 3),
including pharyngeal, forelimb, tail, intersomitic, neural tube,
midbrain and nasal ectoderm expression sites (Fig. 2A). In
contrast, Opa1 transcripts were broadly expressed in the embryo
and riboprobes detecting EST sequences between Opa1 and Hes1,
including the predicted genes 9530020007RIK and GM1968,
revealed either low-level expression in the anterior region of the
embryo or no expression (Fig. 2B). Together, these results suggest
that Hes1 may be the endogenous target of the cis-regulatory
sequences trapped by the T55 transgene.
Additional gene expression studies were carried out to test this
hypothesis. The distribution of Hes1 transcripts was compared
with that of nlacZ, together with b-galactosidase expression, in T55
embryos at E10.5 and E12.5. At E10.5, T55 and Hes1 expression
overlapped in pharyngeal epithelia, the pericardial region and the
forelimb (Figs 3A, 4A). T55 transcripts accumulated in a subset of
Hes1 expression sites in the central nervous system, including
specific populations of neurons in the brain and ventral neural
tube (Fig. 3A). At E12.5, expression of the transgene and Hes1 was
observed in the interdigital region of the developing limb-buds and
pulmonary endoderm (Fig. 3B). These experiments revealed that
Figure 1. Molecular characterization of the T55 transgene integration site. (A) Fluorescent in situ hybridization to metaphase chromosomes
prepared from T55 splenocytes showing transgene localization to chromosome 16 B2–B4. (B) Map of the T55 integration site (top) and endogenous
locus (bottom) showing the structure of the 39 end of the transgene array (black box, A17 Myf5 enhancer; blue box, nlacZ reporter gene) and the
position of the inverse PCR primers (red arrowheads); B, BamHI; Bg, BglII. Also shown are the flanking sequence isolated by inverse PCR (red) and the
Southern blot probe (grey) used to identify the predicted 5.5 kb BamHI fragment in transgenic DNA in addition to a 3.8 kb wildtype fragment (C). (D)
Ensembl map of the genomic region surrounding the integration site (red arrow) on chromosome 16, showing the position of the flanking genes
Opa1 and Hes1 and intermediate gene predictions based on EST alignments.
doi:10.1371/journal.pone.0006267.g001
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expression sites.
Hes1 is expressed in the second heart field
In T55 embryos, b-galactosidase activity is detected in the
superior wall of the OFT and contiguous pericardial mesoderm at
E10.5 [27]; nlacZ transcripts in T55 positive embryos accumulate
in pericardial mesoderm but were not observed in the myocardial
OFT wall. b-galactosidase activity in the OFT wall is thus the
result of either extremely low-level transcription or b-galactosidase
perdurance from prior transcription in OFT progenitor cells
(Fig. 4A). At this timepoint Hes1 transcripts accumulate in
pericardial mesoderm; after extensive staining, Hes1 transcript
accumulation was detected in cells in the superior wall of the OFT
(Fig. 4A). Hes1 transcripts also accumulate at low-level in cells
likely to correspond to cardiac neural crest cells in the distal OFT;
T55 transgene expression is also observed in these cells (Fig. 4A).
Analysis of earlier developmental timepoints revealed that the T55
transgene is expressed in splanchnic mesoderm dorsal to the heart
tube at E8.5 (Fig. 4B) [27]. Endogenous Hes1 transcripts were
observed in the dorsal pericardial wall and in mesoderm lateral to
the pharynx, in addition to pharyngeal epithelia and neuroecto-
derm. The expression of Hes1 in pharyngeal mesoderm overlaps
with that of Fgf10; however, the mesodermal expression domain of
Fgf10 extends further, both in a posterior direction and into cranial
mesoderm, than that of Hes1 (Fig. 4C). Hes1 is therefore
coexpressed with Fgf10 in pharyngeal mesoderm dorsal to the
early heart tube, including the region of the SHF.
Heart defects in Hes1 mutant mice
Hes1 mutant mice die during late fetal development with defects
affecting neural, eye, pancreas, pituitary and lung development,
among other organs [22–26]. This phenotype reflects the critical
role of Hes1 in maintaining progenitor cell populations and
regulating differentiation during organogenesis [22]. In order to
investigate whether Hes1 is required for SHF development, we
analyzed cardiac development in Hes1 mutant mice. SHF defects
affect OFT formation and arterial pole alignment [1,4,7] and
embryos were scored at E15.5 for abnormalities in ventriculoar-
terial alignment. During normal development, the ascending aorta
obtains an independent connection with the left ventricle and the
pulmonary trunk with the right ventricle. 21/127 Hes1
2/2
embryos were recovered (expected 32/127; p.0.05)) and 8/21
(38%) mutant embryos displayed an externally visible dextraposed
ascending aorta; this phenotype was not observed in Hes1
+/2 or
Hes1
+/+ embryos (Fig. 5A). Histological sections of selected
embryos revealed that the aorta failed to obtain a dorsal position
with respect to the pulmonary trunk resulting in a ventricular
septal defect and overriding aorta (observed in 3 out of 4 Hes1
2/2
hearts with a dextraposed aorta that were sectioned). The extent to
which the aorta overrides the right ventricle was ,50% in the
hearts scored (Fig. 5). Overriding aorta and ventricular septal
defects were not observed in 1 of the 4 sectioned hearts with a
dextraposed aorta or in 6 additional Hes1
2/2 hearts without an
externally visible dextraposed aorta. No defects were observed on
histological analysis of 5 Hes1
+/2 and 5 Hes1
+/+ hearts. Loss of
Hes1 therefore results in defects in normal alignment of the aorta
and left ventricle during cardiac remodeling in a significant
fraction of mutant embryos.
The etiology of this defect was analyzed by examining Hes1
2/2
embryos at earlier stages of heart development. In order to
visualize SHF progenitor cells and OFT development in mutant
embryos, we crossed Hes1
+/2 mice with the Mlc1v-nlacZ-24
transgenic line, in which transgene integration upstream of the
Figure 2. Comparison of transgene and integration site gene expression profiles. (A) E9.5 embryos after X-gal staining (T55 embryo, left) or
in situ hybridization with a lacZ (T55 embryo, middle) or Hes1 riboprobe (right). Overlapping expression sites include the ventral pharyngeal region
(ph), forelimb (fl), ventral neural tube (cns), segmental intersomitic region (s), midbrain (mb), tail region (t) and nasal ectoderm (ne). Asterisk indicates
lacZ riboprobe trapping in the otic vesicle. (B) Expression profiles of Opa1 and two predicted genes mapping to the intergenic region at E9.5.
doi:10.1371/journal.pone.0006267.g002
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including cells of the SHF, OFT and right ventricle (Fig. 6A)
[3]. We analyzed OFT morphology at two different days of
development (E9.5 and E10.5) and measured OFT length and the
angle between the proximal and distal regions of the OFT
(Fig. 6B). OFT length and angle in Hes1
2/2 embryos was
indistinguishable from that of control littermates at E9.5. In
contrast, at E10.5, we observed a significantly increased angle
between the proximal and distal regions of the OFT compared to
somite-matched control littermates; moreover, OFT length was
concomitantly decreased (Fig. 6B). These results demonstrate that
the Hes1
2/2 OFT is shorter and straighter than that of control
littermates at midgestation.
Loss of Hes1 impairs SHF proliferation without altering
differentiation
The decrease in OFT length in Hes1
2/2 embryos is suggestive
of a defect in SHF development. Hes1 is known to maintain
progenitor cell populations in the developing embryo through the
regulation of differentiation and proliferation [22–26]. We
therefore analyzed SHF differentiation at E9.5; no precocious
accumulation of sarcomeric myosin heavy chain or a-actinin was
observed in splanchnic mesodermal SHF cells in the dorsal
pericardial wall of Hes1
2/2 embryos at this stage (Fig. 7A). The
SHF contributes to both myocardium and smooth muscle at the
arterial pole of the heart [2]. Normal myocardial and smooth
muscle differentiation at the base of the great arteries were
observed in mutant hearts at E12.5 using SM22a and a-actinin
immunochemistry (data not shown).
Proliferation within the pharyngeal region of Hes1
2/2 embryos
was evaluated by scoring for the proliferation markers phospho-
Histone H3 and Ki67, revealing M-phase and all proliferating cells
respectively. SHF progenitors were identified in the dorsal
pericardial wall and pharyngeal mesenchyme at E8.5 using Isl1
or b-galactosidase immunochemistry in Mlc1v-nlacZ-24 embryos.
A reduction in the number of phospho-Histone H3 positive
(mitotic) Mlc1v-nlacZ-24 positive cells was observed, from 13.7% in
wildtype embryos to 5.7% in Hes1
2/2 embryos (p,0.001; Fig. 7B,
7C). Moreover, 11.7% of Mlc1v-nlacZ-24 positive cells were Ki67-
negative (non-proliferating) in mutant embryos compared to 5.7%
in wildtype embryos (p,0.001; data not shown). A reduction in
proliferating cell numbers was also observed in pharyngeal
endoderm from 9% in wildtype embryos to 5% in mutant
embryos (p,0.001). These results suggest that cell cycle progres-
sion in the SHF and pharyngeal endoderm is impaired in mutant
embryos. In contrast, no differences in the percentage of phospho-
Histone H3 or Ki67 positive cells were observed in the linear heart
tube of Hes1
2/2 embryos at the same E8.5 timepoint. Equivalent
low numbers of Caspase 3-positive cells were found in the
pharyngeal region of wildtype and mutant embryos, suggesting
that apoptosis levels are unaltered in the absence of Hes1 (data not
shown).
Hes1 has been shown to control proliferation through the
transcriptional repression of cyclin-dependent kinase inhibitors
including p27
kip1 and p57
kip2 [28,29]. We investigated p27
kip1
distribution in the SHF of Hes1
2/2 embryos and observed an
expansion of p27
kip1 positive cells in SHF cells in the dorsal
pericardial wall proximal to the dorsal mesocardium in 3/4
Figure 3. Comparison of T55 and Hes1 expression during embryonic development. (A) E10.5 wholemount embryos (left) and cryosections
after X-gal staining (top) or in situ hybridization with a lacZ (T55 embryo, middle) or Hes1 riboprobe (bottom). The transgene is expressed at a subset
of sites of Hes1 expression including the forelimb (fl), pharyngeal region (including ectoderm, arrowheads), neural tube (nt), including a specific
population of neurons in the ventral neural tube (arrows) and diencephalon (d); ph, pharynx. Asterisk indicates probe trapping in the otic vesicle. (B)
E12.5 forelimb (left) and lung (right) after X-gal staining (top) and nlacZ (middle) or Hes1 (bottom) in situ hybridization, showing similar transgene and
Hes1 expression in the interdigital region (arrows) and pulmonary epithelium (arrowheads). Scale bar: 200 mm.
doi:10.1371/journal.pone.0006267.g003
Hes1 in Heart Development
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2/2 hearts (Fig. 7D). Immunoblot analysis revealed a 2.15
fold increase in p27
kip1 levels in microdissected ventral pharyngeal
regions including the SHF in the absence of Hes1 (Fig. 7E).
Together, these results suggest that loss of Hes1 perturbs
proliferation, but not differentiation, of SHF progenitor cells,
associated with elevated p27
kip1levels.
Cardiac neural crest cell defects in Hes1 mutant embryos
Cardiac neural crest cells are critically required for OFT
septation and normal SHF deployment [6]. In addition to the
above defects in SHF development we observed a reduction in
Crabp1 expression in the region of the 3
rd and 4
th–6
th pharyngeal
arches in Hes1
2/2 embryos at E9.5 (Fig. 8A). Transverse sections
of the caudal pharynx at E9.5 revealed a reduction in AP-2a
positive neural crest cells underlying the pharynx (Fig. 8B).
Quantification of neural crest (AP-2a positive) and SHF (Mlc1v-
nlacZ-24 b-galactosidase positive) nuclei revealed a significant
decrease in neural crest cell numbers in mutant embryos
compared to wildtype littermates (Fig. 8B, 8C). Subsequently,
reduced PlexinA2 transcript accumulation was observed in the
distal OFT of Hes1
2/2 embryos at E11.5 (Fig. 8D). Analysis of
OFT cushion morphology at E11.5 revealed normal cushion
development in the distal region of the OFT although slight
hypocellularity was noted in proximal OFT cushions (Figs 8D,
data not shown). Loss of Hes1 therefore affects two critical cell
populations entering the arterial pole of the heart, the SHF and
cardiac neural crest cells, leading to impaired heart tube
elongation and arterial pole alignment defects at later stages of
development.
Discussion
Here we identify Hes1 as a transcription factor encoding gene
expressed in the SHF and show that Hes1 is required for normal
OFT development. Characterization of the insertion site of the
T55 transgene reveals that Hes1 is the likely endogenous target of
Figure 4. Hes1 is expressed in the second heart field. (A) Comparison of transgene and Hes1 expression in right lateral views of hearts after X-
gal staining and in situ hybridization at E10.5 (left three panels). X-gal positive cells are observed in the distal OFT wall (arrowhead) and pulmonary
endoderm (arrow); nlacZ transcripts are observed in pulmonary endoderm but not the OFT. Low-level Hes1 transcript accumulation is observed in the
distal OFT (black asterisk). Transverse sections (right two panels) show b-galactosidase and low-level Hes1 transcript accumulation in the pericardial
region (white asterisks), superior OFT wall (arrow) and mesenchymal cells in the OFT (arrowhead). (B) At E8.5 X-gal and Hes1 positive cells are
observed in ventral and right views in the pericardial wall (black arrowhead) and pharyngeal mesoderm (white arrowheads) where Fgf10 transcripts
also accumulate. (C) E8.5 sections at the levels indicated in (B), showing Hes1 transcripts in neuroepithelium (ne), endoderm (e) and mesoderm (m)
lateral and ventral to the pharynx, including the SHF (arrowheads), compared with Fgf10 expression. Note that caudally (level e) Hes1 and Fgf10
transcripts are observed in endoderm and mesoderm respectively. ht, heart tube. Scale bars: (A, C) 100 mm.
doi:10.1371/journal.pone.0006267.g004
Hes1 in Heart Development
PLoS ONE | www.plosone.org 5 July 2009 | Volume 4 | Issue 7 | e6267Figure 5. Congenital heart defects in Hes1 mutant mice. (A) E15.5 hearts in ventral wholemount views (left) and cryostat sections at the levels
indicated showing a normal configuration of the ascending aorta (ao) and pulmonary trunk (pt) in Hes1
+/2 hearts (top) and a dextraposed aorta
overriding a ventricular septal defect (arrowhead) in Hes1
2/2 hearts (middle (mild) and bottom (severe)). Note that the aorta in the bottom heart
symmetrically overrides the ventricular septal defect. (B) Paraffin sections of E18.5 hearts in a frontal plane showing a ventricular septal defect
(arrowhead) in a Hes1
2/2 (middle and bottom) but not Hes1
+/+ heart (top). lv, left ventricle; rv, right ventricle. Scale bar: (A) 200 mm; (B) 500 mm.
doi:10.1371/journal.pone.0006267.g005
Figure 6. Outflow tract morphogenesis in Hes1
2/2 embryos. (A) Ventral whole mount views of X-Gal stained hearts from E9.5 and E10.5 Hes1
+/+,
Hes1
+/2 and Hes1
2/2 embryos carrying the Mlc1v-nlacZ-24 transgene. (B) Histograms showing OFT length measurements and the angle between the
proximal and distal region of the OFT from Hes1
+/+, Hes1
+/2 and Hes1
2/2 hearts at E9.5 and E10.5. At E10.5, but not E9.5, Hes1
2/2 embryos display a
shorter, straighter OFT (*, p,0.05; ***, p,0.001, Student’s t-test).
doi:10.1371/journal.pone.0006267.g006
Hes1 in Heart Development
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site lies within a region of conserved synteny between mouse and
zebrafish that may correspond to a genomic regulatory block, such
as have been proposed to contain conserved non-coding elements
targeting developmental regulatory genes [30]. Our data suggest
that regulatory elements within this block control the spatiotem-
poral expression pattern of Hes1. Comparison of T55 and Hes1
expression profiles suggest that the transgene has trapped only a
subset of the cis-regulatory elements mediating Hes1 activation. In
contrast, sites of b-galactosidase accumulation but not Hes1
expression may result from inherent differences in transcript
versus b-galactosidase protein stability. Further differences may
arise from the fact that Hes1 is highly regulated both transcrip-
tionally and post-transcriptionally; oscillations in Hes1 protein
levels play a critical role in measuring developmental time in
unsegmented paraxial mesoderm [21]. b-galactosidase activity in a
subregion of OFT myocardium may thus in part provide a
readout of prior heterogeneity in Hes1 expression in SHF
progenitor cells.
Hes1 is known to be a downstream component of the Notch
signaling pathway and a critical regulator of multiple stem cell
populations in the developing embryo [22]. Accelerated differen-
tiation in Hes1 mutant embryos results in depletion of progenitor
cell populations and a failure of late differentiating cell types [22–
26]. Here we show that Hes1 is required for normal deployment of
SHF progenitor cells. However, we did not observe accelerated
Figure 7. Impact of loss of Hes1 on differentiation and proliferation in the second heart field. (A) Immunochemistry with anti-MHC (left),
anti-a-actinin (right) and anti-b-galactosidase antibodies in transverse sections through the caudal pharyngeal region of an E9.5 embryo carrying the
Mlc1v-nlacZ-24 transgene. Note the b-galactosidase positive a-actinin and MF20 negative cells in the dorsal pericardial wall (arrowheads). Nuclei are
labeled with Hoechst (blue). (B) Immunochemistry with anti-phospho-Histone H3 and anti-b-galactosidase antibodies in paraffin sections of E8.5
Hes1
+/+ and Hes1
2/2 embryos carrying the Mlc1v-nlacZ-24 transgene. (C) Histogram comparing the percentage of phospho-Histone H3 positive nuclei
in pharyngeal endoderm, myocardium and SHF of Hes1
+/+ and Hes1
2/2 embryos. A decrease in phospho-Histone H3 positive nuclei is observed in
Hes1
2/2 SHF and endoderm (p,0.001, Student’s t-test). (D) Immunochemistry with an anti-p27
kip1 antibody in paraffin sections at E8.5. Note that
p27
kip1 is expanded in the SHF of Hes1
2/2 hearts (arrowheads). Nuclei are labeled with Hoechst (blue). (E) Western blot of microdissected heart and
ventral pharyngeal regions of Hes1
+/+ and Hes1
2/2 embryos showing elevated p27
kip1 protein levels in the absence of Hes1. Scale bars (A): 50 mm; (B):
100 mm; (D) 50 mm.
doi:10.1371/journal.pone.0006267.g007
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2/2 embryos. A possible
explanation lies in the observation that Hey1 and Hey2 transcripts
are also detectable in pharyngeal mesoderm (data not shown).
Hes1 can heterodimerize with Hey1 to effect strong transcriptional
repression and Hes1, Hes3 and Hes5 are known to have
overlapping functions in the developing nervous system, uncov-
ered by analysis of compound null embryos [31,32]. Hes1 may
therefore overlap in function with other members of the Hes and
Hey gene families to regulate SHF development. In support of this
argument, overriding aorta has been observed in embryos lacking
Hey2 [17–20].
Hes1 also maintains progenitor cell populations in the
developing embryo by regulating proliferation. In particular,
Hes1 represses transcription of the CDK inhibitors p27
kip1 and
p57
kip2 [28,29]. We observed that levels of the mitotic marker
phospho-Histone H3 are reduced in the SHF of Hes1 mutant
embryos at E8.5, whereas the number of Ki67-negative quiescent
cells is increased. p27
kip1 protein distribution at this stage reflects
the low proliferative nature of differentiated cells in the linear
heart tube. We observed that p27
kip1 was expanded and
upregulated in the dorsal pericardial wall of Hes1 mutant embryos,
consistent with release from Hes1 mediated repression and
providing new mechanistic insights into the regulation of SHF
proliferation.
In addition to reduced proliferation in the SHF, the Hes1
cardiac phenotype is likely to be compounded by the observation
that less neural crest cells are found in the ventral pharyngeal
region and distal OFT of mutant embryos. Hes1
2/2 embryos have
defects in neural development that may affect the number of
migrating neural crest cells [23] and low-level Hes1 transcript
accumulation is observed in neural crest cells in the distal OFT.
Alternatively, loss of endodermal or SHF signals may indirectly
impact on neural crest cell numbers. Neural crest ablation in avian
embryos results in impaired SHF deployment and a shortened
OFT [6,8]; reduction of neural crest in the caudal pharynx could
thus in turn influence SHF development in Hes1
2/2 embryos.
OFT alignment defects in Hes1 mutant embryos have been
independently observed by another group who, in addition, noted
aortic arch artery abnormalities associated with a defective smooth
muscle contribution at E11.5 (P. Scambler, personal communica-
tion). Neural crest cell anomalies may therefore also contribute
directly to the arterial pole phenotype of Hes1 mutant embryos.
While we did not observe defects in great artery smooth muscle
development, slight hypocellularity of OFT cushions could result
Figure 8. Loss of Hes1 impairs neural crest development. (A) In situ hybridization at E9.5 showing decreased Crabp1 transcript accumulation in
the caudal pharyngeal region of Hes1
2/2 compared to Hes1
+/+ embryos (arrowheads). (B) Immunochemistry with anti-AP-2a (red) and anti-b-
galactosidase (green) antibodies in a transverse section through the caudal pharynx of an E9.5 embryo carrying the Mlc1v-nlacZ-24 transgene. (C)
Histograms showing the percentage of b-galactosidase positive nuclei and the percentage of AP-2a positive nuclei in the pharyngeal region of Hes1
+/+
and Hes1
2/2 embryos (left) and the numbers of total, b-galactosidase positive and AP-2a positive nuclei (right). Note the decrease in the number of AP-
2a positive cells in Hes1
2/2 embryos (p,0.001, Student’s t-test). (D) In situ hybridization at E11.5 showing decreased PlexinA2 transcript accumulation in
the OFT of Hes1
2/2 compared to Hes1
+/+ hearts (black arrowheads) in wholemount (top) and transverse sections (middle). Histological analysis reveals
normal OFT cushion morphology in Hes1
2/2 embryos at E11.5 (bottom). Scale bars (B): 50 mm; (D): 200 mm.
doi:10.1371/journal.pone.0006267.g008
Hes1 in Heart Development
PLoS ONE | www.plosone.org 8 July 2009 | Volume 4 | Issue 7 | e6267from reduced neural crest cell numbers. Alternatively, epithelial-
mesenchymal transition of OFT endothelial cells, known to be
regulated by Notch signalling [9], may be defective in Hes1
2/2
embryos, possibly due to a later role of Hes1 in the OFT itself.
Dissecting the requirement for Hes1 in different cell-types by
conditional mutagenesis will determine the relative importance of
different sites of Hes1 expression (including pharyngeal mesoderm,
endoderm, ectoderm, neural crest and endothelial cells) during
OFT morphogenesis.
The early defect in OFT elongation is likely to underlie the
subsequent ventriculoarterial alignment defects observed in fetal
Hes1
2/2 hearts. Intriguingly, a dextraposed aorta and ventricular
septal defect are observed in less than half of mutant embryos
whereas a shorter OFT was observed in all mutant embryos scored
at E10.5. Given that there is no loss of Hes1
2/2 embryos between
E10.5 and E15.5, this suggests that there is a degree of phenotypic
recovery. The embryonic OFT obtains its maximal length at
E10.5 and subsequently becomes incorporated into the ventricular
outlets and non-myocardial base of the great arteries; OFT length
in Hes1
2/2 embryos may be on the borderline of that required to
achieve normal alignment.
Overriding aorta and ventricular septal defects are common
components of human congenital heart defects. Defects in OFT
development in human patients carrying JAGGED1 or NOTCH2
mutations or in mice carrying mutations in Notch ligands,
receptors or target genes demonstrate the importance of this
intercellular signaling pathway in arterial pole development [13–
20]. Notch signaling has also been implicated in neural crest and
valve development [9,12,16]. The regulation of SHF progenitor
cell deployment during heart tube extension may be an additional
mechanism by which Notch intercellular signaling controls heart
development. Future investigation of the upstream control of Hes1
expression in the SHF will test this hypothesis.
Materials and Methods
Mice
A17-Myf5-nlacZ-T55 (T55) and Mlc1v-nlacZ-24 transgenic mice
have been previously described [3,27]. Hes1
+/2 mice were kindly
provided by Franc ¸ois Guillemot (NIMR, UK) and maintained on
a CD1 outbred background [23]. DNA isolated from tail-tips or
yolk sacs was genotyped for Hes1 alleles as described [33]. Mlc1v-
nlacZ-24 and A17-Myf5-nlacZ-T55 transgenic mice were genotyped
by X-gal staining or by PCR [3,27]. Mouse care and procedures
were in accordance with guidelines approved by the Departmental
Direction of Veterinary Services of the French Ministry of
Agriculture.
Isolation of a transgene integration site junction
fragment
Inverse PCR was performed using SphI and BglII digested T55
hemizygous tail-tip DNA, as described [3]. Primers A and B were
used for inverse PCR using the Expand PCR system (Roche). A
2.6 kb PCR product containing 256 bp of flanking sequence was
subcloned using the pGemT-Easy vector (Promega). DNA
sequences were aligned using NCBI BLAST, DNA Strider
(Release 1.4) and the Ensembl mouse genome browser. Southern
blot mapping was carried out with a 770 bp probe generated by
PCR using primers C and D that detects a 3.8 kb wildtype
fragment and a 5.5 kb fragment subsequent to transgene
integration in BamHI digested genomic DNA. PCR validation
was carried out using primers E, F and G. Primers E and F
generate a 500 bp product from the wildtype locus and F and G a
374 bp product after transgene integration.
Oligonucleotide primer sequences
A5 9-AAAACGACGGGATCATCGCGAGCCATGC-39
B5 9-ACTGGAGGCTGAAGTTCAGATGTGCGGC-39
C5 9-GGTGGCAGCAGTAATCCATGATCTTG-39
D5 9-TGTCAAATCAGATCTCTCCAGATGCC-39
E5 9-CCTGCTGCTTTGGACAATGC-39
F5 9-AAGTCGTTGGAGACCTTGTC-39
G5 9-ACCGCTGGATAACGACATTG-39
Wholemount analysis, histology and immunochemistry
Embryos were dated taking the day of the plug as embryonic
day (E) 0.5. Hearts were dissected at E15.5 and analyzed using a
Zeiss Lumar stereo dissecting microscope; selected hearts were
subsequently analyzed after cryostat or paraffin embedding and
sectioning using standard techniques. Sections were stained with
haemotoxilin and eosin or treated for 15 min with antigen
unmasking solution (Vector) prior to immunohistochemistry using
standard protocols. Primary antibodies used were: b-galactosidase
(1/300, Cappel), MF20 (1/20, DSHB), AP-2a (1/25, DSHB clone
3B5), a-actinin (1/200, DSHB), p27
kip1 (1/200, Cell Signaling),
phospho-Histone H3 (1/400, Upstate), Ki67 (1/25, Dako), Isl1 (1/
100, DSHB clones 402D6 and 394D5) and Caspase 3 (1/100, Cell
Signaling). Secondary antibodies used were: anti-mouse Alexa 488
(Interchim), anti-mouse Cy3 (Jackson), anti-rat biotin (Jackson),
anti-rabbit Alexa 488 (Interchim) and anti-rabbit Cy3 (Jackson).
All secondary antibodies were used at a 1/200 dilution. The anti-
rat biotinylated secondary was amplified using the Renaissance
TSA Fluorescence System (Perkin Elmer), according to the
manufacturer’s instructions. Slides were counterstained with
Hoechst and observed using an ApoTome microscope (Zeiss).
Mesenchymal Ap-2a positive nuclei were scored at E9.5 in 5 or
more 7 mm sections, 14 mm apart, from 3 mutant and 3 control
embryos. X-gal staining was carried out as described [3]; embryos
were collected and fixed for 10 min in 4% paraformaldehyde,
extensively washed in 16PBS and stained for 5 hours at 37uCi na
solution containing 4 mg/ml of X-gal. After staining, the samples
were washed in PBS, post-fixed and observed under a Zeiss Lumar
stereomicroscope. For each experiment a minimum of 3 embryos
of each genotype was scored. OFT length and angle were
measured from stereotyped ventral views of X-gal stained Mlc1v-
nlacZ-24 embryos at E9.5 (24–26 somites) and E10.5 (30–35
somites) using Metamorph software.
Immunoblotting
Protein lysates were obtained from microdissected E8.5 hearts
and ventral pharyngeal regions of control and mutant embryos.
Proteins were separated by SDS-PAGE and transferred to
Hybond-C extra membranes (Amersham Biosciences) prior to
blocking with 5% dry milk for 2 hours. Membranes were
incubated overnight at 4uC with primary antibodies (anti-actin,
diluted 1/2000, Sigma; anti-p27kip1, diluted 1/1000, Cell
Signaling Technology) followed by chemiluminescent detection
(Western Lightening, Enhanced Luminol reagent, Perkin Elmer).
Quantification of immunoblots was carried out using Image
Quant TL software (Amersham Biosciences).
In situ hybridization
Whole mount in-situ hybridization was performed as previously
described [3]. The Hes1 riboprobe was synthesised by T7 RNA
polymerase from a 553 bp template amplified by PCR using
primers Hes1F and Hes1R:
Hes1 in Heart Development
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Hes1R 59-GTAATACGACTCACTATAGGGTCAAA-
TAAACTTCCCCAAAGGA-39
The following riboprobes were prepared from plasmid tem-
plates: Crabp1 [34], Fgf10 [3], Isl1 [35], PlexinA2 [36], lacZ [3].
Riboprobes for Opa1, 953002-Rik, Gm1968, Hey1 and Hey2 were
generated using T7 RNA polymerase from PCR amplified
templates. Primer details are avaliable on request. For each
experiment a minimum of two embryos per genotype were scored.
Fluorescent in situ hybridization
Fluorescent in situ hybridization was carried out as described
[37]. Briefly, metaphase spreads were prepared from male mice
carrying the T55 transgene. Concanavalin A-stimulated splenic
cells were cultured for 72 hours with 5-BrdU added for the final
6 hours of culture (60 mg/ml of medium) to ensure chromosomal
R-banding. The biotinylated lacZ probe was mixed with
hybridization solution at a final concentration of 50 mg/ml and
used at 200 ng per slide after competition of aspecific repetitive
sequences. The hybridized probe was detected by fluorescent
isothiocyanate-conjugated avidin (Vector laboratories). Chromo-
somes were counterstained with propidium iodide. A total of 50
metaphase cells were analyzed.
Cell proliferation and apoptosis analysis
Proliferation was evaluated by immunochemical detection of
phospho-Histone H3 and Ki67 at E8.5. Data were obtained from
at least four sections per embryo for three embryos of each
genotype. Equivalent total cell numbers were scored in wildtype
and homozygous null embryos. For phospho-Histone H3 mean
total cell numbers counted per section were 56.1 (endoderm), 59.6
(heart) and 49.4 (Mlc1v-nlacZ-24 transgene positive SHF cells) for
wildtype embryos and 59.2 (endoderm), 52.3 (heart) and 42.5
(Mlc1v-nlacZ-24 transgene positive SHF cells) for Hes1
2/2
embryos. For Ki67 mean total Mlc1v-nlacZ-24 transgene positive
SHF cell numbers counted per section were 62 for wildtype
embryos and 64 for Hes1
2/2 embryos. Statistical analysis was
carried out using Student’s t-test. Cell death was evaluated at E9.5
using a Caspase 3 antibody and scored as above.
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